BRIEF published on 11/10/2025 at 16:35, 24 days 14 hours ago TRIP Secures $40 Million Funding to Accelerate U.S. Market Expansion Funding TRIP Wellness US Expansion Calming Beverages
PRESS RELEASE published on 11/10/2025 at 16:30, 24 days 14 hours ago 029 Group SE: Portfolio company TRIP closes $40m funding round 029 Group SE's portfolio company TRIP successfully closes $40m funding round, signaling robust growth in the functional drinks sector, accelerating U.S. expansion and strengthening partnership with Calm 029 Group SE TRIP Funding Round Wellness Brand Functional Drinks
BRIEF published on 10/02/2025 at 09:05, 2 months 2 days ago 029 Group SE Maintains "HOLD" Rating Amid Key Developments NuWays AG 029 Group SE Limestone Capital TRIP Drinks Financial Results 2025
PRESS RELEASE published on 10/02/2025 at 09:00, 2 months 2 days ago Original-Research: 029 Group SE (von NuWays AG): HOLD Research report on 029 Group SE by NuWays AG reveals strong development of key holdings. Upgrading recommendation to HOLD with higher fair NAVs for Limestone Capital and TRIP Drinks HOLD Recommendation NuWays AG 029 Group SE Research Report Key Holdings
BRIEF published on 10/01/2025 at 15:05, 2 months 3 days ago Limestone Capital Launches Aethos London Shoreditch 029 Group SE Limestone Capital Cultural Exchange Hospitality Expansion Aethos London Shoreditch
PRESS RELEASE published on 10/01/2025 at 15:00, 2 months 3 days ago 029 Group SE: Limestone Capital opens Aethos London Shoreditch Limestone Capital's portfolio company, Aethos, launches its first UK venue in London's Shoreditch, emphasizing connection and community in the experience economy London Limestone Capital Experience Economy Aethos Shoreditch
BRIEF published on 09/26/2025 at 12:05, 2 months 8 days ago 029 Group SE Releases Half-Year Report 2025 Financial Results 029 Group SE Hospitality Expansion Half-Year Report 2025 Consumer Brands Growth
PRESS RELEASE published on 09/26/2025 at 12:00, 2 months 8 days ago 029 Group SE: Publication of Half-Year Report 2025 029 Group SE announces Half-Year Report 2025 with EUR -236,603 result. Strong operational development and strategic investments in Travel & Hospitality and Consumer Brands 029 Group SE Strategic Investments Operational Development Half-Year Report 2025 Travel & Hospitality
BRIEF published on 08/12/2025 at 09:35, 3 months 23 days ago Limestone Capital Invests in Nokken to Boost Global Expansion Global Expansion Sustainability Investment Hospitality Modular Cabins
PRESS RELEASE published on 08/12/2025 at 09:30, 3 months 23 days ago 029 Group SE: Portfolio company Limestone Capital invests in Nokken 029 Group SE's portfolio company Limestone Capital AG acquires over 30% stake in UK-based Nokken, a design-led modular cabin provider, aiming for international expansion and sustainable hospitality ventures International Expansion 029 Group SE Limestone Capital AG Nokken Sustainable Hospitality
Published on 12/05/2025 at 02:35, 4 hours 35 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 10 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 5 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 10 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 10 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 20 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 45 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 55 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 26 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
